本次并购将成为 2025 ...

2025 年 7 月 14 日，美国马萨诸塞州，全球分析仪器领导者 Waters Corporation（纽约证券交易所代码：WAT）宣布，已与医疗技术巨头 Becton, Dickinson & ...

2025年7月14日，美国马萨诸塞州，全球分析仪器领导者Waters Corporation（纽约证券交易所代码：WAT）宣布，已与医疗技术巨头Becton, Dickinson & Company（BD，纽约证券交易所代码：BDX）达成最终协议，将整合BD旗下生物科学及诊断解决方案业务。此次交易通过反向莫里斯信托（Reverse Morris ...

Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Investing.com -- Waters Corporation (NYSE: WAT )股价在宣布与Becton Dickinson (NYSE:BD)的生物科学与诊断解决方案业务达成175亿美元反向莫里斯信托交易后下跌2.2%。消息公布后，BD股价也下跌了2.1%。

BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...

新泽西州富兰克林湖 - 市值520亿美元的医疗技术公司BD（Becton, Dickinson and Company）（NYSE:BDX）周二宣布，其董事会已宣布每普通股派发1.04美元的季度股息。该股息将于2025年9月30日支付给截至2025年9月8日的在册股东。根据 InvestingPro 数据，BD已连续55年保持股息支付，目前收益率为2.37%。

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...

The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading ...

Shares of Waters Corporation (NYSE:WAT) declined 2.2% following the announcement of a $17.5 billion Reverse Morris Trust deal ...

BD and Waters announced an agreement to create a new life science and diagnostics leader through a business combination.

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.